This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novartis Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Richard Stein: Innovator in Bispecific Antibodies
Introduction
Richard Stein is a notable inventor based in Weil am Rhein, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His work focuses on innovative treatments for specific inflammasomopathies, showcasing his commitment to advancing medical science.
Latest Patents
Richard Stein holds a patent for bispecific antibodies aimed at treating NLRC4-GOF inflammasomapathy. This invention involves bivalent bispecific monoclonal antibodies (bbmAb) or their variants, which are designed to alleviate symptoms associated with NLRC4 inflammasomopathy. The patent highlights the potential of these antibodies in providing therapeutic benefits to patients in need.
Career Highlights
Throughout his career, Richard has been associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to collaborate with other experts in the field, further enhancing his contributions to medical research and innovation.
Collaborations
Richard Stein has worked alongside notable colleagues such as Guido Junge and Michael Kiffe. These collaborations have played a crucial role in the development of his innovative solutions in the realm of bispecific antibodies.
Conclusion
In summary, Richard Stein is a distinguished inventor whose work in bispecific antibodies represents a significant advancement in the treatment of inflammasomopathies. His dedication to innovation continues to impact the field of biotechnology positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile